作者: Thomas Dr. Grunwald , Carsten B. Prof.Dr. Schmidt-Weber
DOI:
关键词:
摘要: The invention relates to a pharmaceutical composition made of one or more preparations and comprising physiologically effective dose at least IL-4 and/or IL-13 inhibitor allergene, matrix, wherein the is solved embedded, whereon coated adsorbed, matrix selected as enable prolonged release inhibitor.